Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and Diagnosis von von Itzstein, Mitchell S, Khan, Shaheen, Gerber, David E

Volltext

Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care qualit... von von Itzstein, Mitchell S., Gupta, Arjun, Kernstine, Kemp H., Mara, Kristin C., Khanna, Sahil, Gerber, David E.

Volltext

Association between immune-related adverse event timing and treatment outcomes von Hsiehchen, David, Naqash, Abdul Rafeh, Espinoza, Magdalena, Von Itzstein, Mitchell S., Cortellini, Alessio, Ricciuti, Biagio, Owen, Dwight H., Laharwal, Mehak, Toi, Yukihiro, Burke, Michael, Xie, Yang, Gerber, David E.

Volltext

How lung cancer cells change identity von von Itzstein, Mitchell S, Drapkin, Benjamin J, Minna, John D

Volltext

Acknowledging and addressing real-world challenges to treating immune-related adverse events von von Itzstein, Mitchell S, Gerber, David E, Bermas, Bonnie L, Meara, Alexa

Volltext

Resistance Mechanisms in ROS1-Positive Lung Cancer: New Insight into a Rare but Clinically Important Entity von von Itzstein, Mitchell S, Gerber, David E

Volltext

Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice von von Itzstein, Mitchell S, Yang, Yuqiu, Wang, Yiqing, Hsiehchen, David, Sheffield, Thomas Y, Fattah, Farjana, Popat, Vinita, Ahmed, Murtaza, Homsi, Jade, Dowell, Jonathan E, Rashdan, Sawsan, Lohrey, Jay, Hammers, Hans J, Hughes, Randall S, Wang, Tao, Xie, Yang, Gerber, David E

Volltext

Distinct autoantibody profiles across checkpoint inhibitor types and toxicities von Mu-Mosley, Hong, von Itzstein, Mitchell S, Fattah, Farjana, Liu, Jialiang, Zhu, Chengsong, Xie, Yang, Wakeland, Edward K, Park, Jason Y, Kahl, Brad S, Diefenbach, Catherine S, Gerber, David E

Volltext

Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report von Gonugunta, Amrit S, von Itzstein, Mitchell S, Gerber, David E

Volltext

Use of artificial intelligence chatbots in clinical management of immune-related adverse events von Burnette, Hannah, Pabani, Aliyah, von Itzstein, Mitchell S, Switzer, Benjamin, Fan, Run, Ye, Fei, Puzanov, Igor, Naidoo, Jarushka, Ascierto, Paolo A, Gerber, David E, Ernstoff, Marc S, Johnson, Douglas B

Volltext

Systemic and Intracranial Efficacy of Osimertinib in EGFR L747P-Mutant NSCLC: Case Report von Gerber, David E., Mayer, Melissa, Gagan, Jeffrey, von Itzstein, Mitchell S.

Volltext

Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors von Ahmed, Murtaza, von Itzstein, Mitchell S, Sheffield, Thomas, Khan, Shaheen, Fattah, Farjana, Park, Jason Y, Popat, Vinita, Saltarski, Jessica M, Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Khan, Saad A, Sultana, Nazima, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E

Volltext

Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors von Mundra, Vatsala, Yang, Yuqiu, von Itzstein, Mitchell S., Fattah, Farjana, Gonugunta, Amrit S., Hannan, Raquibul, Pop, Laurentiu M., Zhang, Yuanyuan, Wang, Yiqing, Sheffield, Thomas, Xie, Yang, Dowell, Jonathan E., Homsi, Jade, Rashdan, Sawsan, Park, Jason, Li, Quan-Zhen, Wakeland, Edward K., Gerber, David E.

Volltext

T-cell tolerant fraction as a predictor of immune-related adverse events von Ostmeyer, Jared, Park, Jason Y, von Itzstein, Mitchell S, Hsiehchen, David, Fattah, Farjana, Gwin, Mary, Catalan, Rodrigo, Khan, Shaheen, Raj, Prithvi, Wakeland, Edward K, Xie, Yang, Gerber, David E

Volltext

Type and case volume of health care facility influences survival and surgery selection in cases with early‐stage non–small cell lung cancer von Wang, Shidan, Lai, Sunny, Itzstein, Mitchell S., Yang, Lin, Yang, Donghan M., Zhan, Xiaowei, Xiao, Guanghua, Halm, Ethan A., Gerber, David E., Xie, Yang

Volltext

Contemporary Lung Cancer Screening and the Promise of Blood-Based Biomarkers von von Itzstein, Mitchell S., Gerber, David E., Minna, John D.

Volltext

Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients? von von Itzstein, Mitchell S., Gerber, David E., Minna, John D.

Volltext

Strategies to maximize influenza vaccine impact in older adults von Whitaker, Jennifer A., von Itzstein, Mitchell S., Poland, Gregory A.

Volltext

Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors von von Itzstein, Mitchell S., Gonugunta, Amrit S., Wang, Yiqing, Sheffield, Thomas, Lu, Rong, Ali, Sadia, Fattah, Farjana J., Xie, Donglu, Cai, Jennifer, Xie, Yang, Gerber, David E.

Volltext

Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology von Itzstein, Mitchell S., Railey, Elda, Smith, Mary L., White, Carol B., Sledge, George W., Howell, John R., Lawton, Wendy, Marinucci, Donna M., Unni, Nisha, Gerber, David E.

Volltext